PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether losartan metabolites are effective in
inducing PPARĪ³ target genes in monocytes in losartan-treated patients.
Details
Lead Sponsor:
German Heart Institute
Collaborators:
Charite University, Berlin, Germany Merck Sharp & Dohme Corp. MSD SHARP and DOHME GMBH Haar Germany